Search research articles
Contact Us
Filters
Showing results (521-530 of 543) with videos related to
Page
of 55
Sort By:
European Journal of Medicinal Chemistry
|
May 14, 2025
Discovery of potent substrate-type lysine methyltransferase G9a inhibitors for the treatment of sickle cell disease
Yosuke Nishigaya, Shohei Takase, Tatsunobu Sumiya, et al.
Acta Pharmacologica Sinica
|
February 22, 2020
Publisher Correction: Integrating yeast chemical genomics and mammalian cell pathway analysis
Fu-Lai Zhou, Sheena C Li, Yue Zhu, et al.
Cell
|
January 16, 2016
A Proteome-wide Fission Yeast Interactome Reveals Network Evolution Principles from Yeasts to Human
Tommy V Vo, Jishnu Das, Michael J Meyer, et al.
Journal of Medicinal Chemistry
|
March 24, 2020
Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer
Fumiyuki Shirai, Anna Mizutani, Yoko Yashiroda, et al.
Nature Communications
|
January 12, 2023
A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression
Shohei Takase, Takashi Hiroyama, Fumiyuki Shirai, et al.
Medical Mycology Journal
|
December 2, 2016
Executive Summary of Japanese Domestic Guidelines for Management of Deep-seated Mycosis 2014
Shigeru Kohno, Kazuo Tamura, Yoshihito Niki, et al.
International Journal of Hematology
|
January 13, 2010
Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
Ritsuko Seki, Koichi Ohshima, Koji Nagafuji, et al.
Cancer Science
|
August 7, 2009
Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
Ritsuko Seki, Koichi Ohshima, Tomoaki Fujisaki, et al.
International Journal of Oncology
|
February 12, 2002
The effect of adjuvant 5'-deoxy-5-fluorouridine in early stage breast cancer patients: results from a multicenter randomized controlled trial
Takeshi Tominaga, Masakazu Toi, Osahiko Abe, et al.
Journal of Medicinal Chemistry
|
March 19, 2019
Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors
Fumiyuki Shirai, Takeshi Tsumura, Yoko Yashiroda, et al.
Page
of 55
Search research articles
Search
Showing results (521-530 of 543) with videos related to
Sort By:
Page
of 55
European Journal of Medicinal Chemistry
|
May 14, 2025
Discovery of potent substrate-type lysine methyltransferase G9a inhibitors for the treatment of sickle cell disease
Yosuke Nishigaya, Shohei Takase, Tatsunobu Sumiya, et al.
Acta Pharmacologica Sinica
|
February 22, 2020
Publisher Correction: Integrating yeast chemical genomics and mammalian cell pathway analysis
Fu-Lai Zhou, Sheena C Li, Yue Zhu, et al.
Cell
|
January 16, 2016
A Proteome-wide Fission Yeast Interactome Reveals Network Evolution Principles from Yeasts to Human
Tommy V Vo, Jishnu Das, Michael J Meyer, et al.
Journal of Medicinal Chemistry
|
March 24, 2020
Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer
Fumiyuki Shirai, Anna Mizutani, Yoko Yashiroda, et al.
Nature Communications
|
January 12, 2023
A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression
Shohei Takase, Takashi Hiroyama, Fumiyuki Shirai, et al.
Medical Mycology Journal
|
December 2, 2016
Executive Summary of Japanese Domestic Guidelines for Management of Deep-seated Mycosis 2014
Shigeru Kohno, Kazuo Tamura, Yoshihito Niki, et al.
International Journal of Hematology
|
January 13, 2010
Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
Ritsuko Seki, Koichi Ohshima, Koji Nagafuji, et al.
Cancer Science
|
August 7, 2009
Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
Ritsuko Seki, Koichi Ohshima, Tomoaki Fujisaki, et al.
International Journal of Oncology
|
February 12, 2002
The effect of adjuvant 5'-deoxy-5-fluorouridine in early stage breast cancer patients: results from a multicenter randomized controlled trial
Takeshi Tominaga, Masakazu Toi, Osahiko Abe, et al.
Journal of Medicinal Chemistry
|
March 19, 2019
Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors
Fumiyuki Shirai, Takeshi Tsumura, Yoko Yashiroda, et al.
Page
of 55